Lytic Bacteriophages Against Bacterial Biofilms Formed by Multidrug-Resistant Pseudomonas aeruginosa,Escherichia coli,Klebsiella pneumoniae,and Staphylococcus aureus Isolated from Burn Wounds
Restricted accessResearch articleFirst published online September, 2021
Lytic Bacteriophages Against Bacterial Biofilms Formed by Multidrug-Resistant Pseudomonas aeruginosa,Escherichia coli,Klebsiella pneumoniae,and Staphylococcus aureus Isolated from Burn Wounds
Use of bacteriophages as antibiofilm agents to tackle multidrug-resistant bacteria has gained importance in recent years.
Materials and Methods:
In this study, biofilm formation by Staphylococcus aureus, Pseudomona aeruginosa, Klebsiella pneumoniae, and Escherichia coli under different growth conditions was studied. Furthermore, the ability of bacteriophages to inhibit biofilm formation was analyzed.
Results:
Under dynamic growth condition, wherein the medium is renewed for every 12 h, the amount of biomass produced and log10 colony-forming unit counts of all bacterial species studied was highest when compared with other growth conditions tested. Biomass of biofilms produced was drastically reduced when incubated for 2 or 4 h with bacteriophages vB_SAnS_SADP1, vB_PAnP_PADP4, vB_KPnM_KPDP1, and vB_ECnM_ECDP3. Scanning electron microscopy and confocal laser scanning microscopy analyses indicated that the reduction in biomass was due to the lytic action of the bacteriophages.
Conclusions:
Results of our study reinforce the concept of developing bacteriophages as alternatives to antibiotics to treat bacterial infections.
Get full access to this article
View all access options for this article.
References
1.
WitteboleX, De RoockS, OpalSM. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence. 2014(1);15:226–235.
Gordillo AltamiranoFL, BarrJJ. Phage therapy in the postantibiotic era. Clin Microbiol Rev. 2019; 32(2):e00066–18.
4.
JikiaD, ChkhaidzeN, ImedashviliE, et al.The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90. Clin Exp Dermatol. 2005; 30(1):23–26.
5.
WrightA, HawkinsCH, ÄnggårdEE, et al.A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; A preliminary report of efficacy. Clin Otolaryngol. 2009; 34(4):349–357.
6.
JaultP, LeclercT, JennesS, et al.Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): A randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis. 2019; 19(1):35–45.
7.
BruttinA, BrüssowH. Human volunteers receiving Escherichia coli phage T4 orally: A safety test of phage therapy. Antimicrob Agents Chemother. 2005; 49(7):2874–2878.
8.
SarkerSA, BergerB, DengY, et al.Oral application of Escherichia coli bacteriophage: Safety tests in healthy and diarrheal children from Bangladesh. Environ Microbiol. 2017; 19(1):237–250.
9.
SarkerSA, McCallinS, BarrettoC, et al.Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. Virology. 2012; 434(2):222–232.
10.
GindinM, FebvreHP, RaoS, et al.Bacteriophage for Gastrointestinal Health (PHAGE) Study: Evaluating the safety and tolerability of supplemental bacteriophage consumption. J Am Coll Nutr. 2019; 38(1):68–75.
11.
SchooleyRT, BiswasB, GillJJ, et al.Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2017; 61(10):e00954-17.
12.
SanghaKK, KumarBVS, AgrawalRK, et al.Proteomic characterization of lytic bacteriophages of Staphylococcus aureus isolated from Sewage Affluent of India. Int Sch Res Notes. 2014; 2014:265298.
13.
ChanBK, TurnerPE, KimS, et al.Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evol Med Public Health. 2018; 2018(1):60–66.
14.
JennesS, MerabishviliM, SoentjensP, et al.Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury—A case report. Crit Care. 2017; 21(1):129.
15.
Bertozzi SilvaJ, StormsZ, SauvageauD. Host receptors for bacteriophage adsorption. FEMS Microbiol Lett. 2016; 363(4):fnw002.
16.
ZhuJ, MillerMB, VanceRE, et al.Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc Natl Acad Sci. 2002; 99(5):3129–3134.
17.
LinDM, KoskellaB, LinHC. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017; 8(3):162–173.
18.
Ferriol-GonzálezC, Domingo-CalapP. Phages for biofilm removal. Antibiotics. 2020; 9(5):268.
19.
WatersEM, NeillDR, KamanB, et al.Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa. Thorax. 2017; 72(7):666–667.
20.
SzafrańskiSP, WinkelA, StieschM. The use of bacteriophages to biocontrol oral biofilms. J Biotechnol. 2017; 250:29–44.
21.
Danis-WlodarczykK, OlszakT, ArabskiM, et al.Characterization of the newly isolated lytic bacteriophages KTN6 and KT28 and their efficacy against pseudomonas aeruginosa biofilm. PLoS One. 2015; 10(5):e0127603.
22.
OliveiraA, RibeiroHG, SilvaAC, et al.Synergistic antimicrobial interaction between honey and phage against Escherichia coli biofilms. Front Microbiol. 2017; 8:2407.
23.
RibeiroKVG, RibeiroC, DiasRS, et al.Bacteriophage isolated from sewage eliminates and prevents the establishment of Escherichia coli biofilm. Adv Pharm Bull. 2018; 8(1):85–95.
24.
MaszewskaA, ZygmuntM, GrzejdziakI, et al.Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections. J Appl Microbiol. 2018; 125(5):1253–1265.
25.
AlvesDR, GaudionA, BeanJE, et al.Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. Appl Environ Microbiol. 2014; 80:6694–6703.
26.
AlvesDR, Perez-EstebanP, KotW, et al.A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions. Microb Biotechnol. 2016; 9(1):61–74.
27.
FortiF, RoachDR, CaforaM, et al.Design of a broad-range bacteriophage cocktail that reduces pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob Agents Chemother. 2018; 62(6):e02573-17.
28.
KhalifaL, GelmanD, ShlezingerM, et al.Defeating antibiotic- and phage-resistant Enterococcus faecalis using a phage Cocktail in vitro and in a clot model. Front Microbiol. 2018; 9:326.
29.
FishR, KutterE, WheatG, et al.Bacteriophage treatment of intransigent diabetic toe ulcers: A case series. J Wound Care. 2016; 25(suppl 7):S27–S33.
30.
MarkoishviliK, TsitlanadzeG, et al.A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int J Dermatol. 2002; 41(7):453–458.
IacuminL, ManzanoM, ComiG. Phage inactivation of listeria monocytogenes on san daniele dry-cured ham and elimination of biofilms from equipment and working environments. Microorganisms. 2016; 4(1):4.
34.
KalanLR, BrennanMB. The role of the microbiome in nonhealing diabetic wounds. Ann N Y Acad Sci. 2019; 1435(1):79–92.
35.
LachiewiczAM, HauckCG, WeberDJ, et al.Bacterial infections after burn injuries: Impact of multidrug resistance. Clin Infect Dis. 2017; 65(12):2130–2136.
36.
PintoAM, CerqueiraMA, Bañobre-LópesM, et al.Bacteriophages for chronic wound treatment: From traditional to novel delivery systems. Viruses. 2020; 12(2):235.
37.
OnoS, ImaiR, IdaY, et al.Increased wound pH as an indicator of local wound infection in second degree burns. Burns. 2015; 41(4):820–824.
38.
PallavaliRR, DegatiVL, LomadaD, et al.Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections. PLoS One. 2017; 12(7):e0179245.
39.
ZhaoJ, ZhangZ, TianC, et al.Characterizing the biology of lytic bacteriophage vB_EaeM_ϕEap-3 infecting multidrug-resistant enterobacter aerogenes. Front Microbiol. 2019; 10:420.
40.
MeloLDR, FerreiraR, CostaAR, et al.Efficacy and safety assessment of two enterococci phages in an in vitro biofilm wound model. Sci Rep. 2019; 9(1):6643.
41.
YinY, NiP, DengB, et al.Isolation and characterisation of phages against Pseudomonas syringae pv. actinidiae. Acta Agric Scand Sect B Soil Plant Sci. 2019; 69(3):199–208.
42.
MathurT, SinghalS, KhanS, et al.Detection of biofilm formation among the clinical isolates of staphylococci: An evaluation of three different screening methods. Indian J Med Microbiol. 2006; 24(1):25–29.
43.
StalinN, SrinivasanP. Characterization of Vibrio parahaemolyticus and its specific phage from shrimp pond in Palk Strait, South East coast of India. Biologicals. 2016; 44(6):526–533.
44.
SillankorvaS, NeubauerP, AzeredoJ. Phage control of dual species biofilms of Pseudomonas fluorescens and Staphylococcus lentus. Biofouling. 2010; 26(5):567–575.
45.
GonzálezS, FernándezL, CampeloAB, et al.The behavior of Staphylococcus aureus dual-species biofilms treated with bacteriophage phiIPLA-RODI depends on the accompanying microorganism. Appl Environ Microbiol. 2017; 83(3):e02821-16.
46.
KumariS, HarjaiK, ChhibberS. Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples. Folia Microbiol (Praha). 2010; 55(3):221–227.
47.
FanH, MiZ, FanJ, et al.A fast method for large-scale isolation of phages from hospital sewage using clinical drug-resistant Escherichia coli. African J Biotechnol. 2012; 11(22):6143–6148.
48.
LiL, ZhangZ. Isolation and characterization of a virulent bacteriophage SPW specific for Staphylococcus aureus isolated from bovine mastitis of lactating dairy cattle. Mol Biol Rep. 2014; 41(9):5829–5838.
49.
PirachaZZ, SaeedU, KhurshidA, et al.Isolation and partial characterization of virulent phage specific against Pseudomonas aeruginosa. Glob J Med Res. 2014; 14(1):1–8.
50.
AbedonST, HerschlerTD, StoparD. Bacteriophage latent-period evolution as a response to resource availability. Appl Environ Microbiol. 2001; 67(9):4233–4241.
51.
Al-YassariIH, Al-MolaGA. Characterization of E. coli phage isolated from sewage. Al-Qadisiyah J Vet Med Sci. 2010; 9(2):45.
52.
ErikssonH, MaciejewskaB, LatkaA, et al.A suggested new bacteriophage genus, “Kp34likevirus,” within the Autographivirinae subfamily of podoviridae. Viruses. 2015; 7(4):1804–1822.
53.
Ksik-SzelochA, Drulis-KawaZ, Weber-DabrowskaB, et al.Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae. Virol J. 2013; 10:100.
54.
WangZ, ZhengP, JiW, et al.SLPW: A virulent bacteriophage targeting methicillin-resistant staphylococcus aureus in vitro and in vivo. Front Microbiol. 2016; 7:934.
55.
TajMK, LingJX, BingLL, et al.Effect of dilution, temperature and pH on the lysis activity of t4 phage against E. coli BL21. J Anim Plant Sci. 2014; 24(4):1252–1255.
56.
Naser IBin, HoqueMM, AbdullahA, et al.Environmental bacteriophages active on biofilms and planktonic forms of toxigenic Vibrio cholerae: Potential relevance in cholera epidemiology. PLoS One. 2017; 12(7):e0180838.
57.
TahaOA, ConnertonPL, ConnertonIF, et al.Bacteriophage ZCKP1: A potential treatment for Klebsiella pneumoniae isolated from diabetic foot patients. Front Microbiol. 2018; 9:2127.
58.
PiresD, SillankorvaS, FaustinoA, et al.Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms. Res Microbiol. 2011; 162(8):798–806.
59.
VermaV, HarjaiK, ChhibberS. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Biofouling. 2010; 26(6):729–737.
60.
HughesKA, SutherlandIW, JonesMV. Biofilm susceptibility to bacteriophage attack: The role of phage-borne polysaccharide depolymerase. Microbiology. 1998; 144(pt11):3039–3047.
61.
SagarSS, KumarR, KaisthaSD. Efficacy of phage and ciprofloxacin co-therapy on the formation and eradication of Pseudomonas aeruginosa biofilms. Arab J Sci Eng. 2017; 42:95–103.
62.
SillankorvaS, NeubauerP, AzeredoJ. Isolation and characterization of a T7-like lytic phage for Pseudomonas fluorescens. BMC Biotechnol. 2008; 8:80.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
